featured
Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the American College of Cardiology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI
J Am Coll Cardiol 2021 Nov 23;78(21)2060-2072, M Valgimigli, D Cao, DJ Angiolillo, S Bangalore, DL Bhatt, J Ge, J Hermiller, RR Makkar, FJ Neumann, S Saito, H Picon, R Toelg, A Maksoud, BM Chehab, JW Choi, G Campo, JM De la Torre Hernandez, V Kunadian, G Sardella, H Thiele, O Varenne, P Vranckx, S Windecker, Y Zhou, MW Krucoff, K Ruster, Y Zheng, R MehranFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.